(PO07-49-22) Dietary Geranylgeraniol and Statins May Act Synergistically to Mitigate Oxidative Stress in Obese Mice

The ePoster content is available to NUTRITION 2022 LIVE ONLINE attendees who are logged in.<br><br>If you are registered, log in and then come back here to use this button.

Presenting Author(s)

Maureen L. Meister, MS, RD
– PhD Candidate, Georgia State University, ATLANTA, Georgia, United States

Co-Author(s)

Chwan-Li Shen, PhD
– Professor, Texas Tech University Health Sciences Center, Lubbock, Texas, United States
Rafaela G. Feresin, PhD
– Assistant Professor, Georgia State University, Atlanta, Georgia, United States

Disclosure(s):

Maureen L. Meister, MS, RD: No relevant financial relationship(s) with ineligible companies to disclose.

Chwan-Li Shen, PhD: No relevant financial relationship(s) with ineligible companies to disclose.

Objectives: This study aimed to determine the individual and combined effects of dietary geranylgeraniol (GG) and statins on oxidative stress in high-fat diet (HFD)-fed animals.

Methods: Five-week-old male C57BL/6J mice were stratified by initial body weight into a 2x2 factorial design with four groups: HFD (60% kcal from fat), HFD + statin (120 mg/kg diet), HFD + GG (400 mg/kg diet), or HFD + GG + statin. Following 14 weeks of treatment, mice were sacrificed, and liver was collected for analysis. Protein expression of the pro-oxidant enzyme, NADPH oxidase (NOX) 4, and antioxidant enzymes, superoxide dismutase 2 (SOD2) and catalase, as well as the transcription factor nuclear factor erythroid 2-related factor 2 (NRF2) were assessed by western blot. Results were analyzed by two-way ANOVA followed by Tukey-Kramer post-hoc test.

Results: We found GG supplementation (HFD + GG group) reduced expression of NOX4 in the liver of obese mice, compared with the HFD group (0.41 ± 0.07-fold, n=6, vs. 1.00 ± 0.24-fold, n=6, p=0.02). The combined, but not individual, treatment with statin and GG (HFD + GG + statin group) significantly increased the expression of SOD2 (1.68 ± 0.36-fold, n=5, vs. 1.00 ± 0.12-fold, n=6, p=0.0002) and catalase (2.30 ± 0.57-fold, n=5, vs. 1.00 ± 0.14-fold, n=6, p<0.0001) compared to the HFD group. Interestingly, NRF2 expression was increased only by statin treatment, without GG supplementation (HFD + GG group), (1.00 ± 0.45-fold, n=6, vs. 2.20 ± 0.86-fold, n=6, p=0.03) compared to HFD.

Conclusions: Oral statins and dietary GG have the potential to mitigate oxidative stress individually or in a synergistic manner by attenuating NOX4 and increasing antioxidant enzymes such as SOD2 and catalase.

Funding Sources: American River Nutrition, LLC, Hadley, MA